Table 2.
Key points in managing the pregnant SLE patients
Observant | Timing | Monitoring details | |
---|---|---|---|
Maternal monitoring | Obstetrician | First visit Repeated monthly until 20 weeks Every 2 weeks until 24 weeks Every week until delivery |
History taking, physical examination, urine analysis (if dipstick is positive for protein, measure protein–creatinine ratio) |
Rheumatologist | First visit Repeat every month until postpartum |
History taking, physical examination, complement, anti ds-DNA antibody, SS-A and SS-B antibodies, cardiolipin antibodies, lupus anticoagulant History taking, physical examination, complement |
|
Both | First visit Repeat every month until postpartum |
CBC, chemistry (including uric acid, liver enzymes, creatinine) Protein–creatinine ratio |
|
Fetal monitoring | Obstetrician | Starting at 16 weeks Starting at 24 weeks Repeated every week until delivery |
Echocardiogram BPP, fetal growth, umbilical artery Doppler velocimetry |
Neonatologist | When signs of fetal compromise detected | Consultation for appropriate timing/mode of delivery | |
Cardiologist | When signs of CHB or heart failure detected | Consultation for therapy and appropriate timing/mode of delivery |
Abbreviations: SLE, systemic lupus erythematosus; CBC, complete blood count; BPP, biophysical profile; CHB, congenital heart block; dsDNA, double stranded DNA.